MariMed Inc. (OTCMKTS:MRMD) Sees Large Increase in Short Interest

MariMed Inc. (OTCMKTS:MRMD) was the target of a significant growth in short interest in May. As of May 29th, there was short interest totaling 64,138 shares, a growth of 1,827.8% from the May 14th total of 3,327 shares. Based on an average trading volume of 1,254,952 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are short sold.

MariMed Price Performance

Shares of OTCMKTS:MRMD traded up $0.00 on Wednesday, hitting $0.07. The company had a trading volume of 50,015 shares, compared to its average volume of 583,225. The company has a market cap of $29.54 million, a PE ratio of -2.47 and a beta of 1.30. The business has a 50 day moving average of $0.08 and a 200 day moving average of $0.08. MariMed has a 52-week low of $0.06 and a 52-week high of $0.23. The company has a current ratio of 0.95, a quick ratio of 0.34 and a debt-to-equity ratio of 1.67.

MariMed (OTCMKTS:MRMD) last released its earnings results on Wednesday, May 13th. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). The firm had revenue of $39.48 million during the quarter, compared to analyst estimates of $38.75 million. MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%. As a group, equities analysts anticipate that MariMed will post -0.04 earnings per share for the current fiscal year.

MariMed Company Profile

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.